Novartis booth at AACR 2026
Biotech

Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?

It’s been over four years since Novartis shook up the CAR-T space with its T-Charge platform. But that’s a lifetime in the world of cell therapies.
James Waldron May 22, 2026 8:28am
Missed target failed trial trial failure

Biogen axes Denali-partnered Parkinson’s drug after phase 2 flop

May 22, 2026 6:12am
Magnifying glass focusing on womens health

OSE turns up the heat on ovarian cancer with phase 2 win

May 22, 2026 7:14am
Top drug launches of 2026

BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions

May 22, 2026 10:00am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Former FDA leader takes new biotech Turn—Chutes & Ladders

May 22, 2026 8:30am
lung
Favicon Fierce Pharma

ASCO: Merck, Kelun's sac-TMT combo beats Keytruda by 65% on PFS

May 21, 2026 5:00pm
More News

Betting on biotech: Prediction markets turn to clinical trials

May 21, 2026 10:30am

Lilly’s triple-G drug drives deep weight loss in phase 3 trial

May 21, 2026 10:27am

Liminatus pays $320M in stock for CAR-T biotech InnocsAI

May 21, 2026 8:09am

Infex advances lung disease candidate after clearing phase 2a

May 21, 2026 4:29am